Shandong Jincheng Pharmaceutical and Chemical Co Ltd Cash Flow Reinvestment Rate
Shandong Jincheng Pharmaceutical and Chemical Co Ltd cash flow reinvestment rate. Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Cash Flow Reinvestment Rate of 0.49x as of September 2025, reinvesting CN¥38.83 Million (capex CN¥38.83 Million ) from operating cash flow of CN¥79.81 Million. See 300233 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Cash flow reinvestment rate of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025. Historical reinvestment intensity for Shandong Jincheng Pharmaceutical and Chemical Co Ltd across 18 annual periods. Explore 300233 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Cash Flow Reinvestment Rate by Year (2008–2025)
Shandong Jincheng Pharmaceutical and Chemical Co Ltd cash flow reinvestment rate by year from 2008 to 2025. Year-by-year capital reinvestment analysis for Shandong Jincheng Pharmaceutical and Chemical Co Ltd. For the full cash flow conversion analysis, see 300233 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | CN¥102.08 Million | CN¥319.64 Million | CN¥100.88 Million | ▼ -35.3% |
| 2024 | 0.49x | CN¥146.29 Million | CN¥296.59 Million | CN¥142.61 Million | ▼ -5.2% |
| 2023 | 0.52x | CN¥345.61 Million | CN¥664.08 Million | CN¥342.90 Million | ▼ -81.8% |
| 2022 | 2.86x | CN¥731.49 Million | CN¥255.63 Million | CN¥373.67 Million | ▲ +147.6% |
| 2021 | 1.16x | CN¥505.25 Million | CN¥437.19 Million | CN¥376.14 Million | ▲ +44.0% |
| 2020 | 0.80x | CN¥438.44 Million | CN¥546.13 Million | CN¥272.44 Million | ▲ +22.3% |
| 2019 | 0.66x | CN¥379.29 Million | CN¥577.98 Million | CN¥361.65 Million | ▼ -43.2% |
| 2018 | 1.16x | CN¥406.96 Million | CN¥352.20 Million | CN¥349.88 Million | ▼ -11.2% |
| 2017 | 1.30x | CN¥197.63 Million | CN¥151.83 Million | CN¥193.80 Million | ▲ +50.5% |
| 2016 | 0.87x | CN¥208.89 Million | CN¥241.48 Million | CN¥158.89 Million | ▲ +10.8% |
| 2015 | 0.78x | CN¥162.35 Million | CN¥207.92 Million | CN¥159.85 Million | ▲ +7.4% |
| 2014 | 0.73x | CN¥159.57 Million | CN¥219.46 Million | CN¥159.57 Million | ▼ -57.4% |
| 2013 | 1.71x | CN¥160.18 Million | CN¥93.92 Million | CN¥160.18 Million | ▲ +35.2% |
| 2012 | 1.26x | CN¥109.21 Million | CN¥86.61 Million | CN¥109.21 Million | ▼ -41.4% |
| 2011 | 2.15x | CN¥135.00 Million | CN¥62.69 Million | CN¥135.00 Million | ▲ +73.6% |
| 2010 | 1.24x | CN¥134.78 Million | CN¥108.67 Million | CN¥134.78 Million | ▲ +41.5% |
| 2009 | 0.88x | CN¥92.58 Million | CN¥105.62 Million | CN¥92.58 Million | ▼ -49.9% |
| 2008 | 1.75x | CN¥52.87 Million | CN¥30.23 Million | CN¥52.87 Million | — |